VanEck Vectors Biotech ETF Company profile
Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. This ETF offers targeted exposure to the biotech industry, a corner of the health care sector that is capable of delivering big returns but also exhibiting significant volatility. Given that risk/return profile, accessing biotech through the exchange-traded wrapper has some obvious appeal; it allows investors to spread out exposure, thereby increasing the opportunity of holding a stock that hits it big.Latest shares articles
UK Outlook Deteriorates as CPI Surges to 3%: Market Implications
UK inflation rose more than expected in January, putting pressure on the UK economy and the Bank of England.
10:09, 19 February 2025
Defence stocks propel DAX 40 and STOXX 600 to new highs
European stocks reach new all-time highs as increased defence spending is expected in Europe
20:02, 18 February 2025
USD forecast - third party data round up
Has the USD stabilised? Learn what’s been driving the US dollar price and whether it has any more upside potential in our USD forecast.
23:29, 17 February 2025
RBA expected to cut interest rates for the first time since 2020
The RBA is widely expected to lower the cash rate by 25 basis points to 4.10% in its first meeting of 2025. With Australia’s economy showing signs of stagnation and inflation tracking below forecasts, market expectations for a rate cut have surged.
09:11, 17 February 2025
Ratings and Reviews
Ratings and Reviews
